Bone level targeting-ultrasonic triggering type drug delivery system, preparation method and application
A delivery system and trigger-based technology, which is applied in the fields of pharmaceutical formulations, drug combinations, bone diseases, etc., can solve the problems of reducing the bioavailability of drugs at the injury site, lack of targeting, and low concentration of drug distribution in bone tissue, so as to improve drug delivery. Effects of enrichment concentration and drug bioavailability, improvement of drug stability, and reduction of normal tissue toxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Such as figure 1 As shown, the bone level targeting-ultrasound-triggered drug delivery system provided by the embodiment of the present invention includes an external level bone tissue targeting-ultrasound-triggered liposome and an internal level two osteoblast-targeted drug-loaded liposome , the external primary bone tissue targeting-ultrasound-triggered liposomes and the internal secondary osteoblast targeting drug-loaded liposomes are both amphiphilic phospholipid molecules with a hydrophilic shell and core and hydrophobic A liposome with a double-layer structure, the inner secondary osteoblast-targeted drug-loaded liposome is encapsulated in the hydrophilic inner core of the outer primary bone tissue-targeted-ultrasound-triggered liposome;
[0041] The outer first-level bone tissue targeting-ultrasound-triggered liposome and the inner second-level osteoblast-targeting drug-loaded liposome are respectively connected with a first-level bone tissue-targeting molecule a...
Embodiment 2
[0051] The bone-level targeted-ultrasound-triggered drug delivery system and its preparation method provided in the embodiment of the present invention are the same as those in the embodiment 1, the only difference is that step S1 is different, and the specific operation process of step S1 in the embodiment of the present invention is as follows:
[0052] S1. Combine 244.4mg of Chol-PEG-Mal with 92.85mg of (DSS) 6 Dissolve in 10ml of N,N-dimethylformamide (DMF), pass through argon, stir at room temperature for 24h, use high performance liquid phase to monitor the reaction process, and wait for (DSS) 6 After the reaction is complete, use a dialysis bag (the molecular weight of the dialysis bag is 3000Da) to remove the unreacted cholesterol-PEG-Mal by dialysis, use a freeze dryer to dry the obtained reaction end product, and perform nuclear magnetic resonance and infrared spectrum detection on it to further determine The synthesized product is the target product, and the sample ...
Embodiment 3
[0054] The bone-level targeted-ultrasound-triggered drug delivery system and its preparation method provided in the embodiment of the present invention are the same as those in the embodiment 1, the only difference is that step S1 is different, and the specific operation process of step S1 in the embodiment of the present invention is as follows:
[0055] Combine 366.6mg of Chol-PEG-Mal with 92.85mg of (DSS) 6Dissolve in 10ml of N,N-dimethylformamide (DMF), pass through argon, stir at room temperature for 24h, use high performance liquid phase to monitor the reaction process, and wait for (DSS) 6 After the reaction is complete, use a dialysis bag (the molecular weight of the dialysis bag is 3000Da) to remove the unreacted cholesterol-PEG-Mal by dialysis, use a freeze dryer to dry the obtained reaction end product, and perform nuclear magnetic resonance and infrared spectrum detection on it to further determine The synthesized product is the target product, and the sample is st...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


